Selumetinib Paediatric NF1 Japan Study

Clinical trial NCT04495127 · COMPLETED

Trial details

NCT number: NCT04495127
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Neurofibromatosis Type 1

Start date: 2020-08-31
Primary completion: 2021-06-16
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.